Biotech Values

[poorgradstudent]

Discussion of positive Abraxane trial in pancreatic cancer, with musings on the (somewhat questionable) economics:

Just to get it out of the way, I think this regimen is approvable because all the reported endpoints (at least to date) are all strongly in favour of abraxane. The "disappointment" by the biotech investing cognoscenti is misplaced / silly.

That said, I won't disagree with the concern over the economics. But it would be nice if one of these quotes went past the usual chin stroking to some type of actual idea / initiative / discussion. I'm honestly at a loss of what to do, but I'm sure people who treat these diseases day in and day out would have some insight into what is possible. Perhaps reporters could actually ask their interviewees for some ideas rather than getting the usual quote.